Cadrenal Therapeutics Inc (CVKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 2,734 | 3,734 | 3,928 | 4,278 | 2,460 |
| Operating Income | -2,734 | -3,734 | -3,928 | -4,278 | -2,460 |
| Other Income | 48 | 67 | 83 | 91 | 52 |
| Pre-tax Income | -2,686 | -3,667 | -3,845 | -4,187 | -2,408 |
| Net Income Continuous | -2,686 | -3,667 | -3,845 | -4,187 | -2,408 |
| Net Income | $-2,686 | $-3,667 | $-3,845 | $-4,187 | $-2,408 |
| EPS Basic Total Ops | -1.31 | -1.87 | -2.09 | -2.75 | -2.18 |
| EPS Basic Continuous Ops | -1.31 | -1.87 | -2.09 | -2.75 | -2.18 |
| EPS Diluted Total Ops | -1.31 | -1.87 | -2.09 | -2.75 | -2.18 |
| EPS Diluted Continuous Ops | -1.31 | -1.87 | -2.09 | -2.75 | -2.18 |
| EPS Diluted Before Non-Recurring Items | -1.31 | -1.87 | -2.09 | -2.74 | -2.18 |
| EBITDA(a) | $-2,733 | $-3,734 | $-3,923 | $-4,278 | $-2,460 |